【金工】公募基金抱团趋势持续下滑，增持通信、医药生物、非银金融行业——2025Q2公募基金季报分析（祁嫣然/马元心）

Core Viewpoint - The public fund industry shows a positive trend in total scale and investor preferences, with a notable shift towards bond-type products and overseas assets, while equity funds see mixed performance [3][4]. Group 1: Public Fund Overview - As of Q2 2025, the total scale of public funds reached 34.4 trillion yuan, reflecting a 6.76% increase from Q1 2025 and a 10.65% year-on-year growth [3]. - Investor preference remains strong for stable-return bond products, with significant interest in commodity and overseas assets [3]. - Bond-type products show a mixed internal structure, with bond FOF, short-term pure bond, passive index bond, and enhanced index bond funds seeing growth rates exceeding 10% [3]. Group 2: Active Equity Funds - The scale of active equity funds remained stable in Q2 2025, with a total of 3.04 trillion yuan, reflecting a slight decrease of 0.88% [4]. - The median stock position of active equity funds increased to 90.32%, indicating a slight recovery in asset allocation [4]. - There is an increased allocation to the ChiNext, Hong Kong stocks, and the Beijing Stock Exchange, while the main board and STAR Market saw reduced allocations [4]. Group 3: Sector and Stock Preferences - Active managers increased their positions in financial real estate, defense, pharmaceuticals, and TMT sectors, with notable increases in communication, pharmaceutical biology, and non-bank financial industries [5]. - The TMT sector shows significant internal differentiation, with high interest in communication and computing power, while consumer electronics and robotics face reduced funding [6]. - The top five holdings include Tencent Holdings, CATL, Kweichow Moutai, Midea Group, and Zijin Mining, with a decrease in concentration among the top 20 holdings [6]. Group 4: Fund Performance and Trends - The market is experiencing structural rotation, with a decline in the trend of fund manager clustering, indicating a lack of consensus on core asset investment opportunities [6]. - High-performing funds are primarily from the Beijing Stock Exchange and pharmaceutical themes, demonstrating strong capital attraction for actively managed products [7].